The PCR-based Septin9 methylation assay, approved for early detection of colorectal cancer (CRC) in the USA, Europe, and China, measures plasma methylation levels of a CpG-rich fragment located in the Septin9 gene promoter [19]. Here, SEPTIN9 is linked to colorectal carcinoma.